Skip to main content

Masticatory Muscle Pain Biomarkers

  • Chapter
  • First Online:

Abstract

This chapter focuses on the potential role of biomarkers for masticatory muscle pain, i.e., myalgia. To date, no biomarkers have been identified that can be used clinically for diagnosis or treatment of myalgia of jaw muscles. There is evidence from microdialysis studies that intramuscular levels of glutamate and serotonin are elevated in patients with chronic myalgia, including myalgia of jaw muscles. High muscle levels of glutamate and serotonin correlate to pain intensity and mechanical allodynia, and both glutamate and serotonin have been shown to induce pain and mechanical hyperalgesia when injected into jaw muscles. This pain, consequently, can be blocked with specific receptor antagonists, indicating that glutamate and serotonin may be promising biomarker candidates. However, muscle levels of glutamate and serotonin do not correlate to plasma levels, which is a disadvantage since measuring intramuscular biomarker levels with currently available techniques is too complicated to be clinically useful. Nerve growth factor (NGF) has also been shown to cause long-lasting hyperalgesia, albeit with no pain, when injected into jaw muscles, but muscle biopsies did not show any differences in NGF levels between patients with jaw myalgia and pain-free controls. Additionally, muscle levels of prostaglandins, bradykinin, or substance P, commonly characterized pain mediators, do not seem to be elevated in myalgic jaw muscles. Because pain mediation and peripheral sensitization are complex events that involve many substances, future research should focus on investigating intramuscular profiles of multiple biomarkers. This, in turn, is possible with newly developed methods, such as proteomics and metabolomics.

The author declares no conflict of interest.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28:6–27.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mense S. Muscle pain: mechanisms and clinical significance. Dtsch Arztebl Int. 2008;105(12):214–9.

    PubMed  PubMed Central  Google Scholar 

  3. Kamper SJ, Maher CG, Hush JM, Pedler A, Sterling M. Relationship between pressure pain thresholds and pain ratings in patients with whiplash-associated disorders. Clin J Pain. 2011;27(6):495–501.

    Article  PubMed  Google Scholar 

  4. Atkinson AJJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, et al. Biomarkers Definition Working Group-Bethesda. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95.

    Article  Google Scholar 

  5. Huang W, Sowa G. Biomarker development for musculoskeletal diseases. PM R J Injury Function Rehabil. 2011;3(6 Suppl 1):S39–44.

    Article  Google Scholar 

  6. Larsson B, Bjork J, Henriksson KG, Gerdle B, Lindman R. The prevalences of cytochrome C oxidase-negative and superpositive fibres and ragged-red fibres in the trapezius muscle of female cleaners with and without myalgia and of female healthy controls. Pain. 2000;84:379–87.

    Article  PubMed  Google Scholar 

  7. McMahon SB, Bennet DLH, Bevan S. Inflammatory mediators and modulators of pain. In: Koltzenburg M, McMahon SB, editors. Wall and Melzack’s textbook of pain. 5th ed. Philadelphia: Elsevier/Churchill Livingstone; 2005. p. 49–72.

    Google Scholar 

  8. Miller KE, Hoffman EM, Sutharshan M, Schechter R. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther. 2011;130(3):283–309.

    Article  PubMed  Google Scholar 

  9. Ernberg M. Serotonin receptors. In: Cairns BE, editor. Peripheral receptor targets for analgesia. Hoboken: John Wiley & Sons, Inc; 2009. p. 243–74.

    Chapter  Google Scholar 

  10. McKelvey L, Shorten GD, O'Keeffe GW. Nerve growth factor-mediated regulation of pain signaling and proposed new intervention strategies in clinical pain management. J Neurochem. 2013;124(3):276–89.

    Article  PubMed  Google Scholar 

  11. Boix F, Roe C, Rosenborg L, Knardahl S. Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain. J Appl Physiol (1985). 2005;98(2):534–40.

    Article  Google Scholar 

  12. Trevisani M, Szallasi A. Vanilloid (TRPV1) and other transient receptor potential channels. In: Cairns BE, editor. Peripheral receptor targets for analgesia: novel approaches to pain management. Hoboken: John Wiley & Sons, Inc.; 2009. p. 175–213.

    Chapter  Google Scholar 

  13. Hoyer D, Bartfai T. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach Chem Biodiversity. 2012;9(11):2367–87.

    Article  Google Scholar 

  14. Alstergren P. Cytokines (tumor necrosis factor, interleukins) and prostaglandins. In: Cairns BE, editor. Peripheral receptor targets for analgesia. Hoboken: John Wiley & Sons, Inc.; 2009. p. 419–54.

    Chapter  Google Scholar 

  15. Tegeder L, Zimmermann J, Meller ST, Geisslinger G. Release of algesic substances in human experimental muscle pain. Inflammation Res Off J Eur Histamine Res Soc [et al.]. 2002;51(8):393–402.

    Article  Google Scholar 

  16. Graven-Nielsen T. Fundamentals of muscle pain, referred pain, and deep tissue hyperalgesia. Scand J Rheumatol Suppl. 2006;122:1–43.

    Article  PubMed  Google Scholar 

  17. Rosendal L, Blangsted AK, Kristiansen J, Sogaard K, Langberg H, Sjogaard G, et al. Interstitial muscle lactate, pyruvate and potassium dynamics in the trapezius muscle during repetitive low-force arm movements, measured with microdialysis. Acta Physiol Scand. 2004;182(4):379–88.

    Article  PubMed  Google Scholar 

  18. Svensson P, Cairns BE, Wang K, Hu JW, Graven-Nielsen T, Arendt-Nielsen L, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain. 2003;101(3):221–7.

    Article  PubMed  Google Scholar 

  19. Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2001;86(2):782–91.

    PubMed  Google Scholar 

  20. Castrillon EE, Cairns BE, Wang K, Arendt-Nielsen L, Svensson P. Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women. Pain. 2012;153(4):823–9.

    Article  PubMed  Google Scholar 

  21. Castroflorio T, Falla D, Wang K, Svensson P, Farina D. Effect of experimental jaw-muscle pain on the spatial distribution of surface EMG activity of the human masseter muscle during tooth clenching. J Oral Rehabil. 2012;39(2):81–92.

    Article  PubMed  Google Scholar 

  22. Castrillon EE, Cairns BE, Ernberg M, Wang K, Sessle B, Arendt-Nielsen L, et al. Glutamate-evoked jaw muscle pain as a model of persistent myofascial TMD pain? Arch Oral Biol. 2008;53(7):666–76.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Svensson P, Wang K, Arendt-Nielsen L, Cairns BE, Sessle BJ. Pain effects of glutamate injections into human jaw or neck muscles. J Orofac Pain. 2005;19(2):109–18.

    PubMed  Google Scholar 

  24. Wang C, Ge HY, Ibarra JM, Yue SW, Madeleine P, Arendt-Nielsen L. Spatial pain propagation over time following painful glutamate activation of latent myofascial trigger points in humans. J Pain. 2012;13(6):537–45.

    Article  PubMed  Google Scholar 

  25. Svensson P, Wang K, Arendt-Nielsen L, Cairns BE. Effects of NGF-induced muscle sensitization on proprioception and nociception. Exp Brain Res. 2008;189(1):1–10.

    Article  PubMed  Google Scholar 

  26. Wang K, Svensson P, Sessle BJ, Cairns BE, Arendt-Nielsen L. Interactions of glutamate and capsaicin-evoked muscle pain on jaw motor functions of men. Clin Neurophysiol. 2010;121(6):950–6.

    Article  PubMed  Google Scholar 

  27. Arendt-Nielsen L, Svensson P, Sessle BJ, Cairns BE, Wang K. Interactions between glutamate and capsaicin in inducing muscle pain and sensitization in humans. Eur J Pain. 2008;12(5):661–70.

    Article  PubMed  Google Scholar 

  28. Cairns BE, Svensson P, Wang K, Castrillon E, Hupfeld S, Sessle BJ, et al. Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males. Exp Brain Res. 2006;169(4):467–72.

    Article  PubMed  Google Scholar 

  29. Castrillon EE, Cairns BE, Ernberg M, Wang K, Sessle BJ, Arendt-Nielsen L, et al. Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: a randomized, double-blinded, placebo-controlled trial. J Orofac Pain. 2008;22(2):122–30.

    PubMed  Google Scholar 

  30. Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain. 2000;85(1–2):31–9.

    Article  PubMed  Google Scholar 

  31. Babenko V, Graven-Nielsen T, Svensson P, Drewes AM, Jensen TS, Arendt-Nielsen L. Experimental human muscle pain induced by intramuscular injections of bradykinin, serotonin, and substance P. Eur J Pain. 1999;3(2):93–102.

    Article  PubMed  Google Scholar 

  32. Babenko V, Svensson P, Graven-Nielsen T, Drewes AM, Jensen TS, Arendt-Nielsen L. Duration and distribution of experimental muscle hyperalgesia in humans following combined infusions of serotonin and bradykinin. Brain Res. 2000;853(2):275–81.

    Article  PubMed  Google Scholar 

  33. Jensen K, Tuxen C, Pedersen-Bjergaard U, Jansen I, Edvinsson L, Olesen J. Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine. Peptides. 1990;11:1127–32.

    Article  PubMed  Google Scholar 

  34. Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain. 2000;84(2–3):339–46.

    Article  PubMed  Google Scholar 

  35. Christidis N, Ioannidou K, Milosevic M, Segerdahl M, Ernberg M. Changes of hypertonic saline-induced masseter muscle pain characteristics, by an infusion of the serotonin receptor type 3 antagonist granisetron. J Pain. 2008;9(10):892–901.

    Article  PubMed  Google Scholar 

  36. Louca S, Ernberg M, Christidis N. Influence of intramuscular granisetron on experimentally induced muscle pain by acidic saline. J Oral Rehabil. 2013;40(6):403–12.

    Article  PubMed  Google Scholar 

  37. Christidis N, Nilsson A, Kopp S, Ernberg M. Intramuscular injection of granisetron into the masseter muscle increases the pressure pain threshold in healthy participants and patients with localized myalgia. Clin J Pain. 2007;23(6):467–72.

    Article  PubMed  Google Scholar 

  38. Christidis N, Kopp S, Ernberg M. The effect on mechanical pain threshold over human muscles by oral administration of granisetron and diclofenac-sodium. Pain. 2005;113(3):265–70.

    Article  PubMed  Google Scholar 

  39. Muller W, Stratz T. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron. Scand J Rheumatol Suppl. 2004;119:44–8.

    Article  PubMed  Google Scholar 

  40. Farber L, Stratz TH, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res. 2001;21(1):1–13.

    PubMed  Google Scholar 

  41. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain. 2003;104(1–2):241–7.

    Article  PubMed  Google Scholar 

  42. Svensson P, Castrillon E, Cairns BE. Nerve growth factor-evoked masseter muscle sensitization and perturbation of jaw motor function in healthy women. J Orofac Pain. 2008;22(4):340–8.

    PubMed  Google Scholar 

  43. Andersen H, Arendt-Nielsen L, Svensson P, Danneskiold-Samsoe B, Graven-Nielsen T. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res. 2008;191(3):371–82.

    Article  PubMed  Google Scholar 

  44. Arima T, Svensson P, Arendt-Nielsen L. Capsaicin-induced muscle hyperalgesia in the exercised and non-exercised human masseter muscle. J Orofac Pain. 2000;14(3):213–23.

    PubMed  Google Scholar 

  45. Sohn MK, Graven-Nielsen T, Arendt-Nielsen L, Svensson P. Inhibition of motor unit firing during experimental muscle pain in humans. Muscle Nerve. 2000;23(8):1219–26.

    Article  PubMed  Google Scholar 

  46. Wang K, Arendt-Nielsen L, Svensson P. Capsaicin-induced muscle pain alters the excitability of the human jaw-stretch reflex. J Dent Res. 2002;81(9):650–4.

    Article  PubMed  Google Scholar 

  47. Arima T, Arendt-Nielsen L, Minagi S, Svensson P. Effect of capsaicin-evoked jaw-muscle pain on intramuscular blood-flow. Arch Oral Biol. 2009;54(3):241–9.

    Article  PubMed  Google Scholar 

  48. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J. Algesia and local responses induced by neurokinin A and substance P in human skin and temporal muscle. Peptides. 1989;10(6):1147–52.

    Article  PubMed  Google Scholar 

  49. Jensen K, Norup M. Experimental pain in human temporal muscle induced by hypertonic saline, potassium and acidity. Cephalalgia. 1992;12:101–6.

    Article  PubMed  Google Scholar 

  50. Mork H, Ashina M, Bendtsen L, Olesen J, Jensen R. Induction of prolonged tenderness in patients with tension-type headache by means of a new experimental model of myofascial pain. Eur J Neurol. 2003;10(3):249–56.

    Article  PubMed  Google Scholar 

  51. McGregor NR, Zerbes M, Niblett SH, Dunstan RH, Roberts TK, Butt HL, et al. Pain intensity, illness duration, and protein catabolism in temporomandibular disorder patients with chronic muscle pain. J Orofac Pain. 2003;17(2):112–24.

    PubMed  Google Scholar 

  52. Dawson A, Ghafouri B, Gerdle B, List T, Svensson P, Ernberg M. Effects of experimental tooth clenching on pain and intramuscular release of 5-HT and glutamate in patients with myofascial TMD. Clin J Pain. 2015;31:9–740.

    Article  Google Scholar 

  53. Castrillon EE, Ernberg M, Cairns BE, Wang K, Sessle BJ, Arendt-Nielsen L, et al. Interstitial glutamate concentration is elevated in the masseter muscle of myofascial temporomandibular disorder patients. J Orofac Pain. 2010;24(4):350–60.

    PubMed  Google Scholar 

  54. Rosendal L, Larsson B, Kristiansen J, Peolsson M, Sogaard K, Kjaer M, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain. 2004;112(3):324–34.

    Article  PubMed  Google Scholar 

  55. Gerdle B, Larsson B, Forsberg F, Ghafouri N, Karlsson L, Stensson N, et al. Chronic widespread pain: increased glutamate and lactate concentrations in the trapezius muscle and plasma. Clin J Pain. 2014;30(5):409–20.

    PubMed  Google Scholar 

  56. Larsson B, Rosendal L, Kristiansen J, Sjogaard G, Sogaard K, Ghafouri B, et al. Responses of algesic and metabolic substances to 8 h of repetitive manual work in myalgic human trapezius muscle. Pain. 2008;140(3):479–90.

    Article  PubMed  Google Scholar 

  57. Flodgren GM, Crenshaw AG, Alfredson H, Fahlstrom M, Hellstrom FB, Bronemo L, et al. Glutamate and prostaglandin E2 in the trapezius muscle of female subjects with chronic muscle pain and controls determined by microdialysis. Eur J Pain. 2005;9(5):511–5.

    Article  PubMed  Google Scholar 

  58. Gerdle B, Lemming D, Kristiansen J, Larsson B, Peolsson M, Rosendal L. Biochemical alterations in the trapezius muscle of patients with chronic whiplash associated disorders (WAD)--a microdialysis study. Eur J Pain. 2008;12(1):82–93.

    Article  PubMed  Google Scholar 

  59. Gerdle B, Soderberg K, Salvador Puigvert L, Rosendal L, Larsson B. Increased interstitial concentrations of pyruvate and lactate in the trapezius muscle of patients with fibromyalgia: a microdialysis study. J Rehabil Med. 2010;42(7):679–87.

    Article  PubMed  Google Scholar 

  60. Ashina M, Stallknecht B, Bendtsen L, Pedersen JF, Schifter S, Galbo H, et al. Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache. Cephalalgia. 2003;23(2):109–16.

    Article  PubMed  Google Scholar 

  61. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Lundeberg T, Kopp S. Pain, allodynia, and serum serotonin level in orofacial pain of muscular origin. J Orofac Pain. 1999;13(1):56–62.

    PubMed  Google Scholar 

  62. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci. 1999;65(3):313–25.

    Article  PubMed  Google Scholar 

  63. Ghafouri B, Larsson BK, Sjors A, Leandersson P, Gerdle BU. Interstitial concentration of serotonin is increased in myalgic human trapezius muscle during rest, repetitive work and mental stress – an in vivo microdialysis study. Scand J Clin Lab Invest. 2010;70(7):478–86.

    Article  PubMed  Google Scholar 

  64. Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol. 2005;99(5):1977–84.

    Article  PubMed  Google Scholar 

  65. Christidis N, Cairns BE, Kumar U, Dong X, Rosén A, Kopp S, Ernberg M. Expression of 5-HT3 receptors and TTX insensitive sodium channels (NaV1.8) by masseter muscle nerve fibers in healthy subjects compared to patients with local myalgia. J Headache Pain. 2014;15(1):63.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand. 2001;59(6):348–55.

    Article  PubMed  Google Scholar 

  67. Basi DL, Velly AM, Schiffman EL, Lenton PA, Besspiata DA, Rankin AM, et al. Human temporomandibular joint and myofascial pain biochemical profiles: a case-control study. J Oral Rehabil. 2012;39(5):326–37.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Sjogaard G, Rosendal L, Kristiansen J, Blangsted AK, Skotte J, Larsson B, et al. Muscle oxygenation and glycolysis in females with trapezius myalgia during stress and repetitive work using microdialysis and NIRS. Eur J Appl Physiol. 2010;108(4):657–69.

    Article  PubMed  Google Scholar 

  69. Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89(1):16–23.

    Article  PubMed  Google Scholar 

  70. Rosendal L, Kristiansen J, Gerdle B, Sogaard K, Peolsson M, Kjaer M, et al. Increased levels of interstitial potassium but normal levels of muscle IL-6 and LDH in patients with trapezius myalgia. Pain. 2005;119(1–3):201–9.

    Article  PubMed  Google Scholar 

  71. Slade GD, Conrad MS, Diatchenko L, Rashid NU, Zhong S, Smith S, et al. Cytokine biomarkers and chronic pain: Association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness. Pain. 2011;152(12):2802–12.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol. 2012;242(1–2):33–8.

    Article  PubMed  Google Scholar 

  73. Linnman C, Appel L, Fredrikson M, Gordh T, Soderlund A, Langstrom B, et al. Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammation. PLoS One. 2011;6(4):e19182.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Hedenberg-Magnusson B, Brodda Jansen G, Ernberg M, Kopp S. Effects of isometric contraction on intramuscular level of neuropeptide Y and local pain perception. Acta Odontol Scand. 2006;64(6):360–7.

    Article  PubMed  Google Scholar 

  75. McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC. NO-mediated alterations in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain. 2006;120(1–2):161–9.

    Article  PubMed  Google Scholar 

  76. Louca S, Christidis N, Ghafouri B, Gerdle B, Svensson P, List T, Ernberg M. Serotonin, glutamate and glycerol are released after the injection of hypertonic saline into the human masseter muscles – a microdialysis study. J Headache Pain. 2014;15(1):89.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. J Pharmacol Exp Ther. 2002;302(3):1146–50.

    Article  PubMed  Google Scholar 

  78. Walder RY, Benson CJ, Sluka KA. Acid-sensing ion channels and pain. In: Cairns BE, editor. Peripheral receptor targets for analgesia. Hoboken: John Wiley & Sons, Inc.; 2009. p. 153–74.

    Chapter  Google Scholar 

  79. Castrillon EE, Cairns B, List T, Svensson P, Ernberg M. Acidic saline-induced pain as a model for experimental masseter myalgia in healthy subjects. Eur J Pain. 2013;17(10):1438–46.

    Article  PubMed  Google Scholar 

  80. Ernberg M, Castrillon EE, Ghafouri B, Larsson B, Gerdle B, List T, et al. Experimental myalgia induced by repeated infusion of acidic saline into the human masseter muscle does not cause the release of algesic substances. Eur J Pain. 2013;17(4):539–50.

    Article  PubMed  Google Scholar 

  81. Ashina M, Jorgensen M, Stallknecht B, Mork H, Bendtsen L, Pedersen JF, et al. No release of interstitial glutamate in experimental human model of muscle pain. Eur J Pain. 2005;9(3):337–43.

    Article  PubMed  Google Scholar 

Additional Reading

  • Christidis N, Omrani S, Fredriksson L, Gjelset M, Louca S, Hedenberg-Magnusson B, Ernberg M. Repeated tender point injections of granisetron alleviate chronic myofascial pain – a randomized, controlled, double-blinded trial. J Headache Pain 2015;16(1):104.

    Article  PubMed  PubMed Central  Google Scholar 

  • Christidis N, Cairns BE, Kumar U, Dong X, Rosén A, Kopp S, Ernberg M. Expression of 5-HT3 receptors and TTX insensitive sodium channels (NaV1.8) by masseter muscle nerve fibers in healthy subjects compared to patients with local myalgia. J Headache Pain. 2014;15(1):63.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gerdle B, Ghafouri B, Ernberg M, Larsson B. Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. J Pain Res. 2014;7:313–26.

    Google Scholar 

  • Shimada A, Castrillon E, Baad-Hansen L, Ghafouri B, Gerdle B, Wåhlén K, Ernberg M, Cairns B, Svensson P. Increased pain and muscle glutamate concentration after single ingestion of monosodium glutamate by myofascial temporomandibular disorders patients. Eur J Pain. 2016;20:1502–12.

    Google Scholar 

  • Simonic-Kocijan S, Zhao X, Liu W, Wu Y, Uhac I, Wang K. TRPV1 channel-mediated bilateral allodynia induced by unilateral masseter muscle inflammation in rats. Mol Pain 2013;9:68. doi: 10.1186/1744-8069-9-68.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wong H, Kang I, Dong XD, Christidis N, Ernberg M, Svensson P, Cairns BE. NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors. Neuroscience. 2014;269:232–44.

    Google Scholar 

  • Xu XX, Cao Y, Ding TT, Fu KY, Li Y, Xie QF. Role of TRPV1 and ASIC3 channels in experimental occlusal interference-induced hyperalgesia in rat masseter muscle. Eur J Pain. 2016;20(4):552–63.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Malin Ernberg DDS, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Germany

About this chapter

Cite this chapter

Ernberg, M. (2017). Masticatory Muscle Pain Biomarkers. In: Goulet, JP., Velly, A. (eds) Orofacial Pain Biomarkers. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53994-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53994-1_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53992-7

  • Online ISBN: 978-3-662-53994-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics